Targeting Epidermal Growth Factor Receptor with Ferrocene-Based Kinase Inhibitors
Organometallics2013Vol. 32(2), pp. 509–513
Citations Over TimeTop 16% of 2013 papers
Jahangir Amin, Irina Chuckowree, Graham J. Tizzard, Simon J. Coles, Minghua Wang, John P. Bingham, John A. Hartley, John Spencer
Abstract
A series of ferrocene analogues based on a 6,7-dimethoxy-N-phenylquinazolin-4-amine template has been synthesized, and two compounds were characterized in the solid state by X-ray crystallography. The compounds have been tested for in vitro anticancer activity, against epidermal growth receptor (EGFR), and submicromolar IC50 values have been determined.
Related Papers
- → Ferrocene-containing non-interlocked molecular machines(2015)94 cited
- → Preparation and characterisation of C60(ferrocene)2(1992)169 cited
- → Möissbauer Study of Fullerene (Ferrocene)2and Decamethyl-Ferrocene(1997)11 cited
- → Syntheses and Characterization of 1,1'-Bis(3-Pyridylethynyl)Ferrocene and 1,1'-Bis(4-Pyridylethynyl)Ferrocene(2001)10 cited
- Type of Ferrocenes on Sensitivities of Ultra-fine AP and Ferrocene Mixture(2011)